The MemTrax Continuous Recognition Test for advanced cognitive impairment screening
2023-07-13
(Press-News.org)
“[...] MemTrax quickly demonstrates and quantifies the pertinent memory dysfunction of Alzheimer’s disease.”
BUFFALO, NY- July 13, 2023 – A new editorial paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 15, Issue 12, entitled, “Advancing screening for cognitive impairment: the memtrax continuous recognition test.”
Extensive efforts to find a treatment for Alzheimer’s disease (AD) span over 40 years, with the often-repeated request for better means to assess the principal dysfunction of this disease, memory impairment. Tremendous costs and resources have already been consumed in the development of treatments for this prevalent and well-recognized condition, e.g., over $40 billion. These pervasive failures support the urgent need for instruments far superior to those used even in recent studies.
The critical impairment in AD is a disorder of neuroplasticity. Thus, cognitive tests which can rapidly, sensitively, frequently, inexpensively, and precisely measure the aspects of memory specifically attacked by AD are principally needed. In this new editorial, researchers J. Wesson Ashford, James O. Clifford and Michael F. Bergeron from Stanford University discuss a continuous recognition test of memory called MemTrax that has been developed to quickly and accurately quantify memory processing, storage and rate of retrieval.
“The precision of MemTrax would best improve the specification of the severity of cognitive impairment in early phases of Alzheimer’s disease, a period of this disease when paper and pencil and historical recollection only provide poor estimates of function [4].”
Further, MemTrax can precisely assess the rate of change over time with repeat testing. By assessing performance metrics and rate of recognition response, MemTrax can screen for many varieties of cognitive impairment and thus would be an ideal tool for use in the elderly U.S. population for the Medicare Annual Wellness Visit. With a test such as MemTrax or other effective online testing, populations can be broadly and inexpensively assessed for AD-related cognitive impairment and then brought into clinical studies to determine what environmental, genetic, or interventional remedies can prevent further development of AD and the pace and/or extent of cognitive decline.
“MemTrax is especially well suited for assessment of very early AD, including early mild cognitive impairment, a time when the focus should be on prevention of AD pathology, not removal of AD pathology.”
Read the full editorial: DOI: https://doi.org/10.18632/aging.204828
Corresponding Author: J. Wesson Ashford
Corresponding Email: ashford@stanford.edu
Keywords: Alzheimer’s disease, memory, online testing, response time, continuous recognition test
Sign up for free Altmetric alerts about this article: https://aging.altmetric.com/details/email_updates?id=10.18632%2Faging.204828
About Aging-US:
Launched in 2009, Aging publishes papers of general interest and biological significance in all fields of aging research and age-related diseases, including cancer—and now, with a special focus on COVID-19 vulnerability as an age-dependent syndrome. Topics in Aging go beyond traditional gerontology, including, but not limited to, cellular and molecular biology, human age-related diseases, pathology in model organisms, signal transduction pathways (e.g., p53, sirtuins, and PI-3K/AKT/mTOR, among others), and approaches to modulating these signaling pathways.
Please visit our website at www.Aging-US.com and connect with us:
SoundCloud
Facebook
Twitter
Instagram
YouTube
LabTube
LinkedIn
Reddit
Pinterest
Click here to subscribe to Aging publication updates.
For media inquiries, please contact media@impactjournals.com.
Aging (Aging-US) Journal Office
6666 E. Quaker Str., Suite 1B
Orchard Park, NY 14127
Phone: 1-800-922-0957, option 1
###
END
ELSE PRESS RELEASES FROM THIS DATE:
2023-07-13
People with more empathy and cosmopolitan beliefs are more likely to support the international sharing of coronavirus vaccines, a new study shows.
During the COVID-19 pandemic, many residents of high-income countries were eligible for COVID-19 vaccine boosters, while many residents of lower-income countries had not yet received a first dose.
Researchers analysed the levels and predictors of international vaccine solidarity through a survey of around 2,000 German adults in the autumn of 2021. They measured their ...
2023-07-13
Québec, July 13, 2023 – Professor Simona Stäger’s team has made a breakthrough in the study of the human immunodeficiency virus (HIV). The researchers have identified the mechanism by which memory CD4+ T lymphocytes—cells that play a major role in our immune response—are predisposed to cell death in people living with HIV. The team’s findings have just been published in JCI Insight.
In this new study, Professor Stäger and her research team built on work done on mice infected with the Leishmania donovani parasite (published in Cell Reports in 2018), which described how a chronic inflammatory environment predisposes ...
2023-07-13
RICHMOND, Va. (July 13, 2023) — A new study by a Virginia Commonwealth University researcher has found that aggression is not always the product of poor self-control but, instead, often can be the product of successful self-control in order to inflict greater retribution.
The new paper, “Aggression As Successful Self-Control,” by corresponding author David Chester, Ph.D., an associate professor of social psychology in the Department of Psychology at VCU’s College of Humanities and Sciences, was published by the journal Social and Personality Psychology Compass and uses meta-analysis to summarize evidence from dozens of existing ...
2023-07-13
A person’s ‘mindreading ability’ can predict how well they are able to cooperate, even with people they have never met before.
Researchers at the University of Birmingham found that people with strong mind reading abilities – the ability to understand and take the perspective of another person’s feelings and intentions– are more successful in cooperating to complete tasks than people with weaker mind reading abilities.
These qualities, also called ‘theory of mind’, are not necessarily related to intelligence and could be improved through training programmes to foster improved cooperation, for example in ...
2023-07-13
Use of low-dose atropine eyedrops (concentration 0.01%) was no better than placebo at slowing myopia (nearsightedness) progression and elongation of the eye among children treated for two years, according to a randomized controlled trial conducted by the Pediatric Eye Disease Investigator Group (PEDIG) and funded by the National Eye Institute (NEI). The trial aimed to identify an effective way to manage this leading and increasingly common cause of refractive error, which can cause serious uncorrectable vision loss later in life. Results from the trial were published in JAMA Ophthalmology.
Importantly, the findings contradict results from recent trials, primarily in East Asia, which ...
2023-07-13
About The Study: In this randomized clinical trial of school-age children in the U.S. with low to moderate myopia (nearsightedness), atropine, 0.01%, eye drops administered nightly when compared with placebo did not slow myopia progression or axial elongation. These results do not support use of atropine, 0.01%, eye drops to slow myopia progression or axial elongation in U.S. children.
Authors: Michael X. Repka, M.D., M.B.A., of the Wilmer Eye Institute in Baltimore, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this ...
2023-07-13
About The Study: This study provides evidence of the clinical effectiveness of mRNA-based vaccines against COVID-19 in patients with cancer. Longevity of immunity in preventing severe COVID-19 outcomes in actively treated patients with cancer, cancer survivors, and matched controls was observed at least five months after the third or fourth dose.
Authors: Raghav Sundar, M.B.B.S., Ph.D., of the National University Health System in Singapore, and Kelvin Bryan Tan, Ph.D., of the Ministry of Health in Singapore, are the corresponding authors.
To access the embargoed study: Visit our ...
2023-07-13
About The Study: In this survey study, all types of objectively measured visual impairment were associated with a higher dementia prevalence. As most visual impairment is preventable, prioritizing vision health may be important for optimizing cognitive function.
Authors: Joshua R. Ehrlich, M.D., M.P.H., of the University of Michigan in Ann Arbor, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamaophthalmol.2023.2854)
Editor’s Note: Please see the article for ...
2023-07-13
RESEARCH REVEALS HOW COVID-19 VIRUS INFECTS THE PLACENTA, AND HOW THIS CAN BE PREVENTED
In a landmark study published in Nature Cell Biology, Australian researchers, led by Professor Jose Polo from Monash University and the University of Adelaide and University of Melbourne’s Professor Kanta Subbarao from the Peter Doherty Institute for Infection and Immunity (Doherty Institute), have revealed how COVID-19 can infect the human placenta.
Research has shown that COVID-19 infections during pregnancy ...
2023-07-13
From Aristotle’s musings on the nature of time to Einstein’s theory of relativity, humanity has long pondered: how do we perceive and understand time? The theory of relativity posits that time can stretch and contract, a phenomenon known as time dilation. Just as the cosmos warps time, our neural circuits can stretch and compress our subjective experience of time. As Einstein famously quipped, “Put your hand on a hot stove for a minute, and it seems like an hour. Sit with a pretty girl for an hour, and it seems like a minute”.
In new work ...
LAST 30 PRESS RELEASES:
[Press-News.org] The MemTrax Continuous Recognition Test for advanced cognitive impairment screening
